APA (7th ed.) Citation

B, F., M, N., M, Z., B, A., M, H., A, V., . . . N, S. (2019). Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial. British journal of haematology, 184(5), 760. https://doi.org/10.1111/bjh.15710

Chicago Style (17th ed.) Citation

B, Friedrichs, et al. "Doubling Rituximab in High-risk Patients with Aggressive B-cell Lymphoma -results of the DENSE-R-MegaCHOEP Trial." British Journal of Haematology 184, no. 5 (2019): 760. https://doi.org/10.1111/bjh.15710.

MLA (9th ed.) Citation

B, Friedrichs, et al. "Doubling Rituximab in High-risk Patients with Aggressive B-cell Lymphoma -results of the DENSE-R-MegaCHOEP Trial." British Journal of Haematology, vol. 184, no. 5, 2019, p. 760, https://doi.org/10.1111/bjh.15710.